Energy Transfer Has Crushed The Market, And I Expect That To Continue

Energy Transfer is highlighted as a top conviction name with a robust 6.4% yield and valuation support, trading at a large discount to peers on price-to-operating cash flow and EV/EBITDA. Management raised 2026 EBITDA guidance to $18.8–$19.1B, citing higher volumes and margins across core segments. Overall, the combination of strong cash generation, improved guidance, and discounted valuation is presented as a favorable near-to-medium term setup.

Analysis

ET’s setup is less about headline growth and more about cash-flow durability versus where the market is still pricing governance/complexity risk. If 2026 EBITDA is even modestly credible, the equity screens as too cheap on a cash yield basis, which matters because midstream rerates usually come from confidence in distributable cash flow persistence, not from absolute growth alone.

The second-order winner is the rest of the large-cap pipeline/Midstream group only if ET’s discount begins to close; otherwise ET can keep outperforming without lifting the whole cohort. More likely relative losers are cleaner, lower-yield peers such as KMI, WMB, and EPD on a valuation basis if capital rotates toward the highest free-cash-flow yield names, but only if investors stop treating ET as a “cheap for a reason” story.

The key risk is that a raised EBITDA guide can overstate equity value if incremental cash is consumed by maintenance capex, debt paydown, or network bottlenecks rather than shareholder returns. The catalyst path is 1-3 months around next earnings, where the market will look for conversion into DCF, leverage progress, and any signal on buybacks/distributions; the 6-18 month structural catalyst is whether management proves it can compound per-share cash flow without new dilution or another capital cycle reset. What would falsify the thesis: narrowing volume/margin momentum, guidance cutback, or a widening credit spread that signals the bond market does not believe the cash-flow story.

Key Decisions for Investors

• Long ET on pullbacks, not strength: better entry after post-guidance digestion, targeting a 10-15% re-rating over 3-6 months if DCF and leverage metrics track the raised EBITDA guide.
• Pair trade: long ET / short KMI for 1-3 months. Thesis is valuation convergence toward the higher cash-yield name; stop if KMI’s capital-return narrative improves or ET fails to show follow-through in the next earnings print.
• Relative-value alert: long ET vs EPD only if ET’s next update confirms stronger incremental margin conversion. EPD remains the cleaner balance-sheet name, so ET needs proof, not just cheapness.
• Watch credit market confirmation: if ET unsecured spreads tighten versus peers over the next 4-8 weeks, that is a signal the equity discount can compress further; if spreads widen, fade the rally.
• If management reaffirms capital returns in the next quarter, consider call spreads rather than stock for a 6-9 month upside capture; if no capital-return catalyst emerges, treat ET as an income hold rather than a rerating trade.